Comparison of the BIG Score and the Pediatric Trauma Score

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 16
SponsorSohag University

About this trial

The goal of this observational study is to evaluate and compare the predictive performance of the BIG Score and the Pediatric Trauma Score (PTS) in predicting mortality among pediatric trauma patients presenting to the emergency department.

The main questions it aims to answer are:

Does the BIG Score accurately predict mortality in pediatric trauma patients?

Is the Pediatric Trauma Score (PTS) effective in predicting mortality among pediatric trauma patients?

Which scoring system demonstrates better sensitivity, specificity, and overall predictive accuracy for mortality?

Researchers will compare the BIG Score with the Pediatric Trauma Score to determine which scoring system provides superior prognostic value in pediatric trauma cases.

Participants will:

Undergo routine clinical assessment upon admission to the emergency department.

Have vital signs, Glasgow Coma Scale (GCS), and trauma-related clinical parameters recorded.

Undergo laboratory investigations including Base Deficit and International Normalized Ratio (INR).

Be followed during hospitalization to assess outcomes, including survival or mortality.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pediatric trauma patients from birth up to 16 years of age.

Presentation to the Emergency Department within 24 hours of the primary injury.

Disqualifiers

Patients with minor traumas who are treated and discharged directly from the ED.

Patients initially managed at and referred from another hospital.

Patients whose legal guardians discharge them against medical advice (AMA) before outcome data can be ascertained.

Trial population

The study will include pediatric patients presenting to the emergency department with traumatic injuries and Eligible according to the inclusion criteria during the study period .

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • blood sampling

    Diagnostic test

    Pediatric trauma patients presenting to the emergency department will undergo routine clinical and laboratory evaluation according to institutional trauma management protocols. Upon admission, physiological and laboratory parameters required for calculation of the BIG Score and the Pediatric Trauma Score (PTS) will be collected. The BIG Score will be determined using Base Deficit, International Normalized Ratio (INR), and Glasgow Coma Scale (GCS), while the Pediatric Trauma Score will be calculated using airway status, systolic blood pressure, level of consciousness, skeletal injury, cutaneous injury, and body weight. Both scores will be assessed during the initial evaluation phase and correlated with patient outcomes, including mortality, intensive care unit admission, need for mechanical ventilation, blood transfusion, and length of hospital stay. No additional therapeutic intervention beyond standard trauma care will be introduced as part of the study.

Treatment groups

150 Participants
are divided into 1 treatment group
Group A: Pediatric patients presenting to the emergency department with traumatic injury.1 intervention

Trial outcomes

Primary outcomes

1

In-hospital mortality among pediatric trauma patients.

The proportion of enrolled pediatric trauma patients who die during hospitalization within 30 days of admission.

Time frame
From admission to discharge (up to 30 days)

Secondary outcomes

1

ICU admission among pediatric trauma patients.

The proportion of enrolled pediatric trauma patients requiring admission to the intensive care unit during hospitalization will be assessed.

Time frame
From admission to discharge (up to 30 days)
2

Emergency surgical intervention among pediatric trauma patients

The proportion of enrolled pediatric trauma patients requiring emergency surgical intervention during hospitalization will be assessed .

Time frame
From admission to discharge (up to 30 days)

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: